Global Insights From The World Leader in Serving Science

The biotech and pharma industry landscape is evolving at an incredible pace. The increasing push for patient-centric medicine, the rapid growth of innovative technologies such as artificial intelligence and predictive modelling, as well as ever-changing governmental regulations around taxation and approvals, all require today's pharma organizations to be more agile, acquire new technologies and identify new business models to compete.

Join, Drew Burch, President of Drug Development and Commercial Operations - Europe, Pharma Services, Thermo Fisher Scientific for an intimate and deep discussion about strategies for overcoming common challenges faced by small and emerging biopharma.